Lupus Foundation of America Event Calls for More Progress for Patients

Optimism and hope. That’s what NBC’s Chuck Todd took away from the Lupus Foundation of America’s National Advocacy Awards Dinner on June 16. Todd moderated a thoughtful discussion among health care...
Read More
New Report: Innovation in the Biopharmaceutical R&D Process – Adapting to a Changing Environment

With the average cost of developing, testing and receiving approval for a new medicine at $2.6 billion and rising, biopharmaceutical companies are continuously looking at new ways to increase...
Read More
Medicare Monday: What is CMMI?

This week Medicare Monday is looking at the Center for Medicare and Medicaid Innovation (CMMI) and why it matters to patients. The Center for Medicare and Medicaid Innovation (CMMI) is a government...
Read More
Week in Review: The Latest from PhRMA

Fighting High Cholesterol: The prevalence of high cholesterol among American adults underscores the importance of continued innovation. Take a look at the new infographic on fighting high cholesterol.
Read More
ICYMI: The Importance of Enrolling in Clinical Trials

Clinical trials are a crucial step in the long and costly process of researching and developing a new medicine to address substantial unmet medical needs in such areas as Alzheimer’s, cancer, and...
Read More
Fighting High Cholesterol

High cholesterol itself is not a disease, but it can lead to disease. After all, every 40 seconds, an American adult dies from a heart attack, stroke, or related vascular disease. Despite being...
Read More
Burden on Patients: 5 Questions on Access to HIV/AIDS Medicines in Health Exchange Plans

Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to HIV/AIDS...
Read More
ASCO’s Framework: Value at the Crossroads

Yesterday the American Society of Clinical Oncology (ASCO) released its long-awaited draft conceptual framework to assess the value of cancer treatment options. PhRMA has long supported the...
Read More
Medicare Monday: Managing Chronic Conditions

According to the Centers for Disease Control and Prevention, two in three older Americans live with multiple chronic conditions. Chronic conditions may include Alzheimer’s and dementia, arthritis,...
Read More
Week in Review: The Latest from PhRMA

Burden on Patients: Access to medicines is important for patients who are managing chronic conditions. In the latest edition of the ”Burden on Patients” series, we’re taking a look at the barriers to...
Read More
Burden on Patients: 5 Questions on Access to Mental Health Medicines in Health Exchange Plans

Patients, especially those suffering from chronic conditions, deserve access to the medicines they need to live longer, healthier lives. Today, PhRMA released a new fact sheet on access to mental...
Read More
Ask About Adherence: Q&A with PhRMA Foundation Young Investigator Adherence Grantee - Xian Shen

Ask About Adherence is a blog series featuring Q&A’s with experts in medication adherence. In this post, we speak with Xian Shen, a 2015 PhRMA Foundation Young Investigator Adherence grantee about...
Read More
Burden on Patients: Access to Medicines in Exchange Plans

Access to prescription medicines is a critical component of health care coverage, particularly for patients living with and managing chronic conditions. In the coming weeks, we’ll be highlighting...
Read More
3 Reasons Innovation Depends On Strong IP Protections in the TPP

As Congress continues to debate Trade Promotion Authority (TPA), it is important to keep in mind why the Trans-Pacific Partnership (TPP) – the largest trade deal in history – can and should help...
Read More
Medicare Monday: Why the Independent Payment Advisory Board is Bad For Patients

The Independent Payment Advisory Board (IPAB) – created by the Affordable Care Act – could come between patients and their health care providers. If Medicare growth exceeds a certain target, IPAB...
Read More
New Study: Policy Environment Has a Significant Impact on Biopharmaceutical Investment

Economies’ policy trajectories have a significant impact on biopharmaceutical investment decisions, perhaps more than costs and market size, according to local executives. A new study from Pugatch...
Read More
New Data on Health Insurance Exchange Plans Shows Cost Sharing Increasing for Some Medicines

One primary reason people buy health insurance is to protect themselves from unpredictable and unaffordable health care costs. But when patients face high coinsurance—meaning they have to pay a...
Read More
Who Benefits from the 340B Drug Discount Program?

The 340B program was created by Congress in 1992 to help vulnerable or uninsured patients gain access to needed prescription medicines, by requiring pharmaceutical manufacturers to provide steep...
Read More
Medicare Monday: New Research on How Successfully Managing Diabetes Helps Patients and Part D Save

An important aspect of Medicare Part D is access to affordable prescription drug coverage so that beneficiaries can get the medicines they need, take them as directed and avoid costly complications...
Read More
Avalere Insights on Latest Evidence Communication Research

Jay Jackson, Nikita Jeswani and Corinna Sorenson are all consultants for Avalere Health and provide strategic counsel to life sciences clients on a variety of policy-related issues. Jackson...
Read More
Week in Review: The Latest from PhRMA

Who is Making Decisions About Your Health? This week, the Catalyst featured key information about fail first and prior authorization processes, which are methods used by health insurers to limit the...
Read More
New Chart Pack: Advancing Innovative Treatment Options for Patients Through Personalized Medicine

We’re at a remarkable time in medicine, where the rapid pace of science is enabling researchers to make tremendous advances against some of the most devastating diseases. One of the most promising...
Read More
Who is Making Decisions About Your Health Care?

AccessBetterCoverage.org is a great resource for understanding health coverage and the right questions to ask when shopping for coverage. Our Insurance Basics address important topics like 5 Things...
Read More
340B Spotlight: A Look at 340B Purchases

If you are familiar with the 340B program, you have probably heard the oft-cited assertion that 340B only represents 2% of pharmaceutical sales.[1] But just because a statistic is widely repeated,...
Read More
Newly Implemented Expanded Access Principles Support Commitment to Patients

Biopharmaceutical companies are committed to helping patients gain access to the best possible care, and its researchers are constantly looking for ways to provide more therapeutic options for...
Read More
New Video: How Medicines Can Curb Health Care Costs

Hospital visits, surgeries and long-term care place a heavy burden on our nation’s health care system, and the weight is only projected to increase. In just the next decade, the U.S. will spend $13.5...
Read More
Upcoming Forum on Improving Critical Tools for Preventing Prescription Drug Abuse

On June 2, the Network for Excellence in Health Innovation (NEHI) will bring experts from across the country to Boston to discuss a critical public health challenge—the abuse of prescription...
Read More
New Research Highlights Gaps in Quality Measures for Cancer Patients

This weekend marked the start of the annual meeting of The American Society of Clinical Oncology (ASCO). This year’s meeting, which features a theme of “Innovation and Illumination,” highlights the...
Read More
Medicare Monday: Protecting Beneficiaries Who Receive Extra Help

Welcome back to #MedicareMonday where this week we’re talking about Medicare Part D’s Extra Help program. The Extra Help Program—also known as Low-Income Subsidies (LIS)—is designed to help Medicare...
Read More